Wednesday, July 17, 2019 2:06:41 PM
"91. The Defendant, Robert Abenante (“Abenante”), is a resident of Vancouver, British Columbia and was, at all material times in 2018, a director and the President and Chief Executive Officer Abattis Corp., with an address for delivery at Suite 224 - 970 Burrard Street, Vancouver, British Columbia.
92. The Defendant, Kent McParland (“McParland”), is a resident of Richmond, British Columbia and was the Chief Financial Officer of Abattis Corp. from May 15, 2018 through the balance of 2018 and became a director of Abbatis Corp. on October 19, 2018, with an address for delivery at #338 – 5600 Andrews Road, Richmond, British Columbia. McParland was also the Chief Financial Officer and a director of Cryptobloc from July 3, 2018 through the remainder of 2018."
Link:
https://docs.wixstatic.com/ugd/1fe227_b16ca3e71cbe4f768915de774f6253d5.pdf
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM